Cue Biopharma, Inc. (CUE) has 20 known insider and institutional holders on record. The largest holder is Azam Usman with 1,875,000 shares. Other notable holders include PASSERI DANIEL R and Levisetti Matteo.
Over the last 12 months, insiders have made 15 transactions in CUE stock — 13 buys (valued at $1.63M) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
CUE Insider Ownership
Top Holder
Azam Usman
1,875,000 shares
Buys (12 mo)
13
$1.63M value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Azam Usman |
Chief Executive Officer |
1,875,000 |
2025-10-02 |
|
| 2 |
Passeri Daniel R |
Chief Executive Officer |
450,000 |
2025-03-25 |
|
| 3 |
Levisetti Matteo |
Chief Medical Officer |
250,000 |
2025-03-25 |
|
| 4 |
Millar Kerri-ann |
Chief Financial Officer |
200,000 |
2025-03-25 |
|
| 5 |
Suri Anish |
President and CSO |
150,000 |
2024-06-07 |
|
| 6 |
Warren Lucinda |
Chief Business Officer |
125,000 |
2025-11-25 |
|
| 7 |
Fox Michael J |
Director |
100,000 |
2024-06-07 |
|
| 8 |
Nasshorn Patricia |
Chief Business Officer |
97,900 |
2023-02-21 |
|
| 9 |
Seidel Ronald D. Iii |
EVP, Head of R&d |
75,000 |
2018-07-25 |
|
| 10 |
Chaparro Rodolfo |
EVP, Head of Immunology |
75,000 |
2018-07-25 |
|
| 11 |
Schuman Gary Alan |
Interim CFO |
66,750 |
2017-12-27 |
|
| 12 |
Mancilla Bethany |
SVP and Chief Business Officer |
65,000 |
2019-03-08 |
|
| 13 |
Baker Daniel G. |
Chief Development Officer |
50,000 |
2025-11-25 |
|
| 14 |
Pienta Kenneth |
Chief Medical Officer |
40,000 |
2022-03-29 |
|
| 15 |
Sandercock Colin |
SVP, General Counsel |
30,000 |
2025-12-05 |
|
| 16 |
Digiandomenico Anthony |
Director |
30,000 |
2019-01-04 |
|
| 17 |
Garzone Pamela |
Director |
24,400 |
2026-01-06 |
|
| 18 |
Driscoll Frederick W |
Director |
24,400 |
2025-01-03 |
|
| 19 |
Broadfoot Jill Marie |
Director |
24,400 |
2026-01-06 |
|
| 20 |
Morich Frank |
Director |
24,400 |
2026-01-06 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-01-02 |
Sarraf Pasha |
Director |
RSU Award |
24,400 |
$0.34 |
$8.3K |
| 2026-01-02 |
Garzone Pamela |
Director |
RSU Award |
24,400 |
$0.34 |
$8.3K |
| 2026-01-02 |
Verheyen Patrick |
Director |
RSU Award |
24,400 |
$0.34 |
$8.3K |
| 2026-01-02 |
Morich Frank |
Director |
RSU Award |
24,400 |
$0.34 |
$8.3K |
| 2026-01-02 |
Kiener Peter A |
Director |
RSU Award |
24,400 |
$0.34 |
$8.3K |
| 2026-01-02 |
Broadfoot Jill Marie |
Director |
RSU Award |
24,400 |
$0.34 |
$8.3K |
| 2025-12-30 |
Sarraf Pasha |
Director |
Informative Buy |
4,229 |
$0.31 |
$1.31K |
| 2025-12-03 |
Sandercock Colin |
SVP, General Counsel |
RSU Award |
70,000 |
$0.70 |
$49K |
| 2025-09-26 |
Sandercock Colin |
SVP, General Counsel |
RSU Award |
30,000 |
$0.70 |
$21K |
| 2025-09-29 |
Baker Daniel G. |
Chief Development Officer |
RSU Award |
50,000 |
$0.72 |
$36K |
| 2025-09-29 |
Warren Lucinda |
Chief Business Officer |
RSU Award |
125,000 |
$0.72 |
$90K |
| 2025-09-29 |
Azam Usman |
Chief Executive Officer |
RSU Award |
1,875,000 |
$0.72 |
$1.35M |
| 2025-09-29 |
Azam Usman |
Officer |
Unknown |
- |
- |
- |
| 2025-06-04 |
Broadfoot Jill Marie |
Director |
RSU Award |
48,800 |
$0.62 |
$30.26K |
| 2025-06-04 |
Broadfoot Jill Marie |
Officer |
Unknown |
- |
- |
- |
